SABBY MANAGEMENT, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 90 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$39,000
-91.9%
30,900
-84.5%
0.02%
-69.4%
Q3 2018$482,000
+37.7%
199,900
+233.2%
0.06%
+93.8%
Q4 2017$350,000
+11.1%
60,000
-60.0%
0.03%
+52.4%
Q3 2017$315,000
-46.2%
150,151
+20.0%
0.02%
-44.7%
Q2 2017$586,000
+25.5%
125,151
+109.6%
0.04%
+52.0%
Q1 2017$467,00059,7000.02%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2018
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders